Pharma solutions
Overview
Cardiometabolic
MASLD/MASH
Autoimmune Disease
Gastrointestinal Disease
Oncology
Clinical Solutions
Overview
LiverMultiScan
MRCP+
CoverScan
Cancer
Perspectum Portal
our Research
Overview
Publications
Research Network
our company
Overview
Senior Management
Board of Directors
News
Contact
Careers
Events
Webinars
Media Center
Research Papers
A curated document list highlighting the utility and performance of LiverMultiScan
Validation studies
Predicting outcomes
Making patients better
Understanding complexity
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Making patients better
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
Validation studies
Decreases in cT1 and liver fat content reflect histological improvement induced by therapies in MASH: a multicentre pooled cohort analysis
Validation studies
Quantitative MRI for monitoring metabolic dysfunction associated steatotic liver disease: A test-retest repeatability study
Understanding complexity
Feasibility of using contrast-free quantitative magnetic resonance imaging for liver sparing stereotactic ablative body radiotherapy
Making patients better
MRI-serum–based score accurately identifies patients undergoing liver transplant without rejection avoiding the need for liver biopsy: A multisite European study
Understanding complexity
Longitudinal Changes in Quantitative Magnetic Resonance Imaging Metrics in Children and Young Adults with Autoimmune Liver Disease
Understanding complexity
Corrected T1 Mapping in Children and Young Adults With Autoimmune Liver Disease: Correlation With Histology
Making patients better
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
Understanding complexity
Diagnosis and management of autoimmune hepatitis
Predicting outcomes
Liver disease is a significant risk factor for cardiovascular outcomes
Making patients better
A low energy totel diet replacement program demonstrates a favorable safety profile and improves liver disease severity in nonalcoholic steatohepatitis
Understanding complexity
Novel multimetric MRI detects improved future liver remnant quality post-dual vein embolization
Understanding complexity
Associations between MRI T1 mapping, liver stiffness, quantitative MRCP, and laboratory biomarkers in children and young adults with autoimmune liver disease.
Understanding complexity
Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis
Validation studies
Clinical utility of MRI biomarkers for identifying NASH patients at high risk of progression: A multi-center pooled data and meta-analysis
Making patients better
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease
Understanding complexity
Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease
Validation studies
Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis
Validation studies
Quantitative multiparametric MRI can aid NASH diagnosis in a Japanese cohort
Predicting outcomes
Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease
Making patients better
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis
Validation studies
Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting cases
Validation studies
Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease
Predicting outcomes
Multiparametric magnetic resonance imaging for the assessment of nonalcoholic fatty liver disease severity
Validation studies
Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
LiverMultiScan Home
Full Publication List
Full publication list
Publication:
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
Publication:
Decreases in cT1 and liver fat content reflect histological improvement induced by therapies in MASH: a multicentre pooled cohort analysis
Publication:
Quantitative MRI for monitoring metabolic dysfunction associated steatotic liver disease: A test-retest repeatability study
Publication:
Feasibility of using contrast-free quantitative magnetic resonance imaging for liver sparing stereotactic ablative body radiotherapy
Publication:
Longitudinal Changes in Quantitative Magnetic Resonance Imaging Metrics in Children and Young Adults with Autoimmune Liver Disease
Publication:
Corrected T1 Mapping in Children and Young Adults With Autoimmune Liver Disease: Correlation With Histology
Publication:
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Publication:
Estimation of field inhomogeneity map following magnitude-based ambiguity-resolved water-fat separation
Publication:
Liver disease is a significant risk factor for cardiovascular outcomes
Publication:
Novel multimetric MRI detects improved future liver remnant quality post-dual vein embolization
Publication:
Associations between MRI T1 mapping, liver stiffness, quantitative MRCP, and laboratory biomarkers in children and young adults with autoimmune liver disease.
Publication:
Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Children and Young Adults With Autoimmune Liver Disease
Publication:
Quantitative MR in Paediatric Patients with Wilson Disease: A Case Series Review
Publication:
Precision medicine for liver tumours with quantitative MRI and whole genome sequencing (Precision1 trial): study protocol for observational cohort study.
Publication:
Technology-Enabled, Evidence-Driven, and Patient-Centered: The Way Forward for Regulating Software as a Medical Device.
Publication:
Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis
Publication:
Greater ectopic fat deposition and liver fibroinflammation and lower skeletal muscle mass in people with type 2 diabetes.
Publication:
Quantitative imaging tests for non-alcoholic fatty liver disease: which, when and why
Publication:
Multi-organ imaging demonstrates the heart-brain-liver axis in UK Biobank participants
Publication:
Quantitative MR in paediatric patients with Wilson disease: a case series review.
Publication:
Clinical utility of MRI biomarkers for identifying NASH patients at high risk of progression: A multi-center pooled data and meta-analysis
Publication:
Patient understanding and experience of non-invasive imaging diagnostic techniques and the liver patient pathway
Publication:
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease
Publication:
Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease
Publication:
Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial
Publication:
Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort
Publication:
Prospective evaluation of the prevalence of nonalcoholic fatty liver disease and steatohepatitis in a large middle-aged United States cohort
Publication:
Hepatic steatosis rather than underlying obesity increases risk of infection and hospitalization for COVID-19
Publication:
Quantitative multiparametric MRI allows safe surgical planning in patients undergoing liver resection for colorectal liver metastases: report of two patients
Publication:
Multiparametric MRI imaging, autoimmune hepatitis, and prediction of disease activity
Publication:
Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis
Publication:
Multiparametric MRI as a non-invasive monitoring tool for children with autoimmune hepatitis
Publication:
Quantitative multiparametric MRI can aid NASH diagnosis in a Japanese cohort
Publication:
Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus
Publication:
A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis
Publication:
rs641738C>T near MBOAT7 is associated with liver fat, ALT, and fibrosis in NAFLD: a meta-analysis
Publication:
Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease
Publication:
Multiparametric MR mapping in clinical decision-making for diffuse liver disease
Publication:
Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease
Publication:
Comparison of liver T1 relaxation times without and with iron correction in pediatric autoimmune liver disease
Publication:
Relationship between magnetic resonance imaging spleen T1 relaxation and other radiologic and clinical biomarkers of liver fibrosis in children and young adults with autoimmune liver disease.
Publication:
Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis
Publication:
Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration
Publication:
Magnitude‐intrinsic water–fat ambiguity can be resolved with multipeak fat modeling and a multipoint search method
Publication:
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis
Publication:
Diagnostic performance of quantitative magnetic resonance imaging biomarkers for predicting portal hypertension in children and young adults with autoimmune liver disease.
Publication:
Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting cases
Publication:
[Poster] The “IDEAL” method for fat quantification and iron-corrected T1 accurately measure the presence and severity of the individual histological features of nonalcoholic steatohepatitis (NASH)
Publication:
Multiparametric magnetic resonance imaging for early detection of diffuse liver disease
Publication:
Cross-sectional, prospective, evaluation of the utility of Multi-parametric MRI imaging in predicting clinically meaningful outcomes in autoimmune hepatitis
Publication:
Multi-parametric MRI imaging in a heterogeneous liver disease: cross-sectional evaluation of a cohort of patients with PSC
Publication:
Multi-parametric MRI as a composite biomarker for NASH and NASH with fibrosis
Publication:
Liver cT1 predicts clinical outcomes in patients with chronic liver disease, equivalent to biopsy
Publication:
The cT1 multi-parametric MRI value is more sensitive and reliable than transient elastography for the non-invasive monitoring of intra-hepatic inflammation/fibrosis response to DAA therapy in CHC patients
Publication:
Validation of a standardized MRI method for liver fat and T2* quantification
Publication:
Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study
Publication:
A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look‐Locker inversion recovery T1 (shMOLLI‐T1) in the liver
Publication:
Multi-parametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
Publication:
Characterisation of liver fat in the UK Biobank cohort
Publication:
Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease
Publication:
Multiparametric magnetic resonance imaging for the assessment of nonalcoholic fatty liver disease severity
Publication:
Ectopic and visceral fat deposition in lean and obese patients with Type 2 Diabetes
Publication:
Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
Publication:
Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
Publication:
Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging
